Concord Biotech

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue320.21258.95439.26217.67260.41
Expenses186.92159.63254.18160.43177.02
EBITDA146.70112.68199.8175.08101.84
EBIT130.44101.25183.6458.7985.74
Profit Before Tax130.33101.15183.5558.7385.68
Net Profit95.7475.92140.3944.0663.06
Financial Ratios
Operating Profit Margin46.34%46.89%46.12%37.54%42.15%
Net Profit Margin30.87%31.09%32.66%21.60%25.73%
Earning Per Share (Diluted)9.157.2613.424.216.03
Dividends Per Share0.000.000.000.000.00